Attached files

file filename
8-K - AMERIGROUP CORPv211894_8k.htm

Amerigroup Reports Q4 Net Income of $79.6 Million or $1.59 per Diluted Share



Full-Year Net Income of $273.4 Million or $5.40 per Diluted Share

VIRGINIA BEACH, Va., Feb. 18, 2011 /PRNewswire-FirstCall/ -- Amerigroup Corporation (NYSE: AGP) today announced that net income for the fourth quarter of 2010 was $79.6 million, or $1.59 per diluted share, versus net income of $40.2 million, or $0.79 per diluted share, for the fourth quarter of 2009.  

For the year ended December 31, 2010, the Company's net income was $273.4 million, or $5.40 per diluted share, versus net income of $149.3 million, or $2.85 per diluted share, for the full-year 2009.

Highlights include:

  • Annual membership increased 143,000 members to approximately 1.9 million at the end of the fourth quarter, an 8.0% increase year-over-year and essentially unchanged from the third quarter of 2010.  
  • Fourth quarter total revenues were $1.5 billion, a 10.2% increase over the fourth quarter of 2009, and a 0.5% increase over the third quarter of 2010.  
  • Health benefits expense was 80.4% of premium revenue for the fourth quarter of 2010.  
  • Selling, general and administrative expenses were 8.0% of total revenues for the fourth quarter of 2010.
  • Cash flow provided by operations was $401.9 million for the full-year ended December 31, 2010 and $199.4 million for the three months ended December 31, 2010.
  • Unregulated cash and investments were $248.6 million as of December 31, 2010 compared to $251.4 million as of September 30, 2010.
  • Medical claims payable, as of December 31, 2010 totaled $510.7 million compared to $521.8 million as of September 30, 2010.
  • Days in claims payable was 39, compared to 40 days in the previous quarter.
  • The Company repurchased approximately 562,000 shares of its common stock during the fourth quarter for $24.4 million.   For the full year, the Company repurchased 3.75 million shares of its common stock for $138.5 million at an average price of $36.96.  
  • On February 1, 2011, the Company began serving STAR+PLUS members in Fort Worth, Texas, offering health care coverage on a full-risk basis to approximately 27,000 members. This expansion is a result of a competitive procurement whereby the Texas Health and Human Services Commission selected Amerigroup's Texas health plan as one of two plans to expand managed health care coverage to seniors and people with disabilities in the six-county service area surrounding Fort Worth.

"We are pleased with the quarter and gratified by the performance of our business.  We continue to help our members obtain the quality health care they need, while helping to save taxpayer dollars," said James G. Carlson, Amerigroup's chairman and chief executive officer.  "We achieved moderate medical cost trends during the year, in part due to effective management by our clinical teams and also due to a more benign environment for medical cost inflation.  We feel good about 2010 and are excited by the opportunities ahead."

Premium Revenue

Premium revenue for the fourth quarter of 2010 increased 10.3% to $1.5 billion compared to $1.4 billion in the fourth quarter of 2009.  Sequentially, premium revenue increased $8.0 million, or 0.5%.  The sequential increase primarily reflects the impact of rate increases in Georgia, Texas and Florida, partially offset by retroactive membership reductions and lower supplemental premium revenue associated with births.

In December, the Company received final confirmation of its rate increase in Georgia, which was retroactive to July 1, 2010.  The Company recognized approximately $0.09 earnings per diluted share in the fourth quarter of 2010 for the retroactive portion of the rate action associated with the third quarter, which included a premium rate increase and implementation of hospital pass-through payments.  

For the year ended December 31, 2010, premium revenue increased 12.1% to $5.8 billion from $5.2 billion for the year ended December 31, 2009.  

Investment Income and Other Revenues

Fourth quarter investment income and other revenues were $4.3 million versus $4.9 million in the fourth quarter of 2009, and compared to $5.0 million in the third quarter of 2010.  The sequential decline was the result of lower rates of return on short-term fixed income securities.

For the full-year 2010, investment income and other revenues were $22.8 million versus $29.1 million in 2009.  

Health Benefits

Health benefits expense, as a percent of premium revenue, was 80.4% for the fourth quarter of 2010 versus 84.6% in the fourth quarter of 2009, and compared to 80.5% in the third quarter of 2010.  For the full-year 2010, the health benefits ratio was 81.6% compared to 85.4% for the full-year 2009.

The health benefits ratio declined slightly from the third quarter of 2010 to the fourth quarter.  The benefit of favorable reserve development and premium rate increases received in the quarter offset normal seasonal increases in medical costs.  Medical cost trends remained at moderate levels during the fourth quarter of 2010, consistent with the Company's experience in the third quarter.  

Favorable reserve development (net of associated accruals for experience rebate in Texas, applicable medical loss ratio floors, and other gain sharing arrangements with state customers) positively impacted the health benefits ratio in the fourth quarter by approximately 210 basis points compared to 180 basis points reported in the third quarter of 2010.  In addition, the effect of the retroactive rate increase in Georgia positively impacted the health benefits ratio by 30 basis points.

Selling, General and Administrative Expenses

Selling, general and administrative expenses were 8.0% of total revenues for the fourth quarter of 2010 versus 7.7% in the fourth quarter of 2009, and compared to 7.1% for the third quarter of 2010.  

Selling, general and administrative expenses increased sequentially due to variable compensation, costs associated with the expansion in Fort Worth, Medicare marketing, as well as spending for claim payment recoveries.

For the full-year 2010, the selling, general and administrative expense ratio was 7.8% compared with 7.6% for the full-year 2009.  

Premium Taxes

Fourth quarter premium taxes were $38.9 million versus $33.2 million for the fourth quarter of 2009, and compared to $40.3 million in the third quarter of 2010.  

For the full-year 2010, premium taxes were $143.9 million versus $134.3 million for the full-year 2009.  

Balance Sheet Highlights

Cash and investments at December 31, 2010 totaled $1.7 billion of which $248.6 million was unregulated compared to $251.4 million of unregulated cash and investments at September 30, 2010.  During the quarter, the Company repurchased approximately 562,000 shares of common stock for $24.4 million, pursuant to its ongoing share repurchase program.  For the full year, the Company repurchased 3.75 million shares of its common stock for $138.5 million at an average price of $36.96.

The debt to total capital ratio decreased to 17.4% as of December 31, 2010 from 18.2% as of September 30, 2010.

Medical claims payable as of December 31, 2010 totaled $510.7 million compared to $521.8 million as of September 30, 2010.  Days in claims payable represented 39 days of health benefits expense compared to 40 days in the previous quarter.  

Included on page 10 is a table presenting the components of the change in medical claims payable for the years ended December 31, 2010 and December 31, 2009.  

Cash Flow Highlights

Cash flow from operations totaled $401.9 million for the twelve months ended December 31, 2010 and $199.4 million for the three months ended December 31, 2010.  The key driver of cash flow in the quarter was solid earnings and accelerated collection of premium revenue in the quarter.  

Fourth Quarter Earnings Call

Amerigroup senior management will discuss the Company's fourth quarter results on a conference call Friday, February 18, 2011 at 8:00 a.m. Eastern Time (ET).  The conference can be accessed by dialing 866-260-3161 (domestic) or 706-679-7245 (international) approximately ten minutes prior to the start time of the call.  A recording of the call may be accessed by dialing 800-642-1687 (domestic) or 706-645-9291 (international) and providing passcode 35392107.  The replay will be available shortly after the conclusion of the call until Friday, February 25, at 11:59 p.m. ET.  The conference call will also be available through the investors' page of the Company's web site, www.amerigroupcorp.com, or through www.earnings.com.  A 30-day replay of this webcast will be available on these web sites beginning approximately two hours following the conclusion of the live broadcast earnings conference call.

About Amerigroup Corporation

Amerigroup, a Fortune 500 Company, coordinates services for individuals in publicly funded health care programs. Serving more than 1.9 million members in 11 states nationwide, Amerigroup accepts all eligible people regardless of age, sex, race or disability. The Company's product offerings do not utilize any individual underwriting nor deny coverage due to pre-existing medical conditions. Amerigroup is dedicated to offering real solutions that improve health care access and quality for its members, while proactively working to reduce the overall cost of care to taxpayers.www.realsolutions.com. Click here for more information about Amerigroup Corporation.

Forward-Looking Statements

This release is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the Securities and Exchange Commission's Fair Disclosure Regulation. This release contains certain ''forward-looking'' statements, including statements regarding moderating medical cost trends and our growth opportunities.  These statements are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results in future periods to differ materially from those projected or contemplated in the forward-looking statements. These risks and uncertainties include, but are not limited to: our inability to manage medical costs; our inability to operate new products and markets at expected levels, including, but not limited to, profitability, membership and targeted service standards; local, state and national economic conditions, including their effect on the rate-setting process and timing of payments; the effect of government regulations and changes in regulations governing the health care industry, including the impact of recently enacted health care reform legislation; changes in Medicaid and Medicare payment levels and methodologies; increased use of services, increased cost of individual services, epidemics, pandemics, the introduction of new or costly treatments and technology, new mandated benefits, insured population characteristics and seasonal changes in the level of health care use; our ability to maintain and increase membership levels; our ability to enter into new markets or remain in existing markets; changes in market interest rates or any disruptions in the credit markets; our ability to maintain compliance with all minimum capital requirements; liabilities and other claims asserted against us; demographic changes; the competitive environment in which we operate; the availability and terms of capital to fund acquisitions, capital improvements and maintain capitalization levels required by state agencies; our ability to attract and retain qualified personnel; the unfavorable resolution of new or pending litigation; and catastrophes, including acts of terrorism or severe weather.

Investors should also refer to our annual report on Form 10-K for the year ended December 31, 2009 filed with the Securities and Exchange Commission ("SEC") and subsequent quarterly reports on Form 10-Q and current reports on Form 8-K filed with or furnished to the SEC, for a discussion of certain known risk factors that could cause our actual results to differ materially from our current estimates. Given these risks and uncertainties, we can give no assurances that any forward-looking statements will, in fact, transpire and, therefore, caution investors not to place undue reliance on them. We specifically disclaim any obligation to update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise.  

AMERIGROUP CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED INCOME STATEMENTS

(dollars in thousands, except per share data)

(unaudited)










Three months ended


Twelve months ended


December 31,


December 31,


2010


2009


2010


2009









Revenues:








Premium

$1,497,928


$1,357,683


$5,783,458


$5,158,989

Investment income and other

4,307


4,902


22,843


29,081

Total revenues

1,502,235


1,362,585


5,806,301


5,188,070

Expenses:








Health benefits

1,204,383


1,148,366


4,722,106


4,407,273

Selling, general and administrative

119,642


105,191


452,069


394,089

Premium taxes

38,935


33,200


143,896


134,277

Depreciation and amortization

8,696


8,299


35,048


34,746

Interest

4,011


3,867


16,011


16,266

Total expenses

1,375,667


1,298,923


5,369,130


4,986,651

Income before income taxes

126,568


63,662


437,171


201,419

Income tax expense

46,940


23,440


163,800


52,140

Net income

$79,628


$40,222


$273,371


$149,279

















Diluted net income per share

$1.59


$0.79


$5.40


$2.85









Weighted average number of common  








shares and dilutive potential common  








shares outstanding

49,924,608


51,069,265


50,608,008


52,309,268



The following table sets forth selected operating ratios.  All ratios, with the exception of the health benefits ratio, are shown as a percentage of total revenues.


Three months ended


Twelve months ended


December 31,


December 31,


2010


2009


2010


2009

Premium revenue

99.7

%


99.6

%


99.6

%


99.4

%

Investment income and other

0.3



0.4



0.4



0.6


Total revenues

100.0

%


100.0

%


100.0

%


100.0

%

Health benefits [1]

80.4

%


84.6

%


81.6

%


85.4

%

Selling, general and administrative expenses

8.0

%


7.7

%


7.8

%


7.6

%

Income before income taxes

8.4

%


4.7

%


7.5

%


3.9

%

Net income

5.3

%


3.0

%


4.7

%


2.9

%













[1] The health benefits ratio is shown as a percentage of premium revenue because there is a direct relationship between the premium received and the health benefits provided.



The following table sets forth the approximate number of members the Company served in each state as of December 31, 2010 and 2009.  Because the Company receives two premiums for members that are both in the Medicare Advantage and Medicaid products, these members have been counted twice in the states where we offer both plans.




December 31,




2010


2009



Texas[1]

559,000


505,000



Georgia

266,000


249,000



Florida

263,000


236,000



Tennessee

203,000


195,000



Maryland  

202,000


194,000



New Jersey

134,000


118,000



New York

109,000


114,000



Nevada

79,000


62,000



Ohio

55,000


60,000



Virginia

40,000


35,000



New Mexico

21,000


20,000



     Total  

1,931,000


1,788,000







[1] Membership includes approximately 14,000 members under an ASO contract in 2010 and 13,000 in 2009.  



The following table sets forth the approximate number of members in each of the Company's products as of December 31, 2010 and 2009.  Because the Company receives two premiums for members that are in both the Medicare Advantage and Medicaid products, these members have been counted in each product.





December 31,



Product

2010


2009



TANF (Medicaid)

1,373,000


1,255,000



CHIP

271,000


259,000



Aged, Blind and Disabled (Medicaid)[1]

197,000


196,000



FamilyCare (Medicaid)

71,000


63,000



Medicare Advantage

19,000


15,000



Total

1,931,000


1,788,000














[1]Membership includes approximately 14,000 members under an ASO contract in 2010 and 13,000 in 2009.



AMERIGROUP CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(dollars in thousands, except per share data)

(unaudited)


December 31,


December 31,


2010


2009







Assets

Current assets:




Cash and cash equivalents

$763,946


$505,915

Short-term investments  

230,007


137,523

Premium receivables  

83,203


104,867

Deferred income taxes  

28,063


26,361

Prepaid expenses, provider and other receivables and other

53,482


47,316

Total current assets

1,158,701


821,982





Property, equipment and software, net

96,967


101,002

Goodwill

260,496


249,276

Long-term investments, including investments on deposit for licensure

754,004


813,976

Other long-term assets  

13,220


13,398


$2,283,388


$1,999,634





Liabilities and Stockholders' Equity

Current liabilities:




Claims payable

$510,675


$529,036

Unearned revenue

103,067


98,298

Accounts payable

7,023


4,685

Accrued expenses and other

230,076


127,278

Total current liabilities

850,841


759,297





Long-term debt

245,750


235,104

Other long-term liabilities

21,160


20,789

Total liabilities

1,117,751


1,015,190





Stockholders’ equity:




Common stock, $.01 par value

554


546

Additional paid-in capital, net of treasury stock

300,453


391,912

Accumulated other comprehensive income

627


1,354

Retained earnings

864,003


590,632

Total stockholders’ equity

1,165,637


984,444


$2,283,388


$1,999,634



AMERIGROUP CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(dollars in thousands)

(unaudited)


Twelve months ended

December 31,


2010


2009



Cash flows from operating activities:




Net income

$273,371


$149,279

Adjustments to reconcile net income to net cash provided by




operating activities:




Depreciation and amortization

35,048


34,746

Loss on disposal of property, equipment and software

354


585

Deferred tax (benefit) expense

(2,262)


818

Compensation expense related to share-based payments

19,635


15,936

Convertible debt non-cash interest expense

10,646


9,974

Gain on sale of intangible assets

(4,000)


-

Gain on sale of contract rights

-


(5,810)

Other

9,219


(167)

Changes in assets and liabilities increasing (decreasing) cash




 flows from operations:




Premium receivables

21,664


(18,272)

Prepaid expenses, provider and other receivables and other




  current assets

(10,818)


(2,310)

Other assets

(691)


(1,146)

Claims payable

(18,361)


(7,071)

Unearned revenue

4,769


15,710

Accounts payable, accrued expenses and other current liabilities

61,967


(43,758)

Other long-term liabilities

1,408


(1,480)

                     Net cash provided by operating activities

401,949


147,034





Cash flows from investing activities:




     Purchase of investments, net

(29,377)


(265,307)

Purchase of investments on deposit for licensure, net

(12,392)


(7,410)

Purchase of property, equipment and software

(29,463)


(29,738)

Proceeds from sale of intangible assets

4,000


-

Proceeds from sale of contract rights

-


5,810

Purchase of contract rights and other related assets

(13,420)


-

                     Net cash used in investing activities

(80,652)


(296,645)





Cash flows from financing activities:




     Repayments of borrowings under credit facility

-


(44,318)

     Change in bank overdrafts

40,890


(2,492)

Proceeds and tax benefits from exercise of stock options




  and other, net

34,384


8,815

Repurchase of common stock shares

(138,540)


(69,751)

                     Net cash used in financing activities

(63,266)


(107,746)

Net increase (decrease) in cash and cash equivalents

258,031


(257,357)

Cash and cash equivalents at beginning of year

505,915


763,272

Cash and cash equivalents at end of year

$763,946


$505,915



AMERIGROUP CORPORATION AND SUBSIDIARIES

Components of the Change in Medical Claims Payable

(dollars in thousands)






Twelve months ended


Twelve months ended


December 31, 2010


December 31, 2009

Medical claims payable, beginning of period

$529,036


$536,107





Health benefits expenses incurred during period:




Related to current year

4,828,321


4,492,590

Related to prior years

(106,215)


(85,317)

Total incurred

4,722,106


4,407,273





Health benefits payments during period:




Related to current year

4,359,216


4,007,789

Related to prior years

381,251


406,555

Total payments

4,740,467


4,414,344





Medical claims payable, end of period

$510,675


$529,036





Health benefits expenses incurred during both periods were reduced for amounts related to prior years.  The amounts related to prior years include the impact of amounts previously included in the liability to establish it at a level sufficient under moderately adverse conditions that were not needed and the reduction in health benefits expenses due to revisions to prior estimates.  




CONTACTS:  

Investors:  Julie Loftus Trudell

Amerigroup Corporation

Senior Vice President, Investor Relations

(757) 321-3597

jtrudell@amerigroupcorp.com


News Media: Maureen C. McDonnell

Amerigroup Corporation

Vice President, External Communications

(757) 473-2731

mmcdonn@amerigroupcorp.com  







CONTACT:  Investors: Julie Loftus Trudell, Senior Vice President, Investor Relations, Amerigroup Corporation, +1-757-321-3597, jtrudell@amerigroupcorp.com, or News Media: Maureen C. McDonnell, Vice President, External Communications, Amerigroup Corporation, +1-757-473-2731, mmcdonn@amerigroupcorp.com